Hormone Therapy including estrogen, progesterone and androgens

This web page contains links to ASRM publications and materials on the general subjects of Hormone Therapy. Some materials are archived in Adobe®Acrobat® PDF format. Please click here for downloading information.

The ASRM publishes a newsletter which addresses all these subjects-- see Menopausal Medicine.

Hormone Therapy for Men

ASRM Practice Guideline: Treatment of androgen deficiency in the aging male published November 2006; under revision. Practice Committee Guidelines are accessible to ASRM members only.

Hormone Therapy for Women

ASRM News Washington Wire: FDA Seeks Enforcement of So-Called “Bioidentical” Compounds (Winter 2008)
ASRM Bulletin: American Society for Reproductive Medicine Comments on Latest WHI Study (March 2008)
ASRM Bulletin: FDA Sends Warning Letters to Pharmacies; Claims about “Bio-Identical HRT” Are False and Misleading (January 2008)
ASRM Press Release: The American Society for Reproductive Medicine Comments on “Estrogen Therapy and Coronary-Artery Calcification" Report to Appear in the New England Journal of Medicine (June 20, 2007)
ASRM Press Release: American Society for Reproductive Medicine Comments on Latest Data Analysis from the Women’s Health Initiative: Study to Appear in the Journal of the American Medical Association (April 3, 2007)
ASRM Practice Guideline: Estrogen and progestogen therapy in postmenopausal women published November 2006; revised January 2008. Practice Committee Guidelines are accessible to ASRM members only
Articles from Fertility and Sterility: The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition (PDF) from Fertil Steril 2004;81:1498-501
FDA Menopause & Hormones Fact Sheet (PDF) (September 2003)
FDA Approves New Labels for Estrogen and Estrogen with Progestin Therapies for Postmenopausal Women Following Review of Women's Health Initiative Data (January 2003)
Comments from the American Society for Reproductive Medicine No Benefit of Menopausal Hormone Therapy (HT) on CNS Outcomes in Older Women
The ASRM Menopause Special Interest Group (MSIG) Addresses the Women's Health Initiative (WHI) Study Results
American Society for Reproductive Medicine Statement on Combined Hormone Therapy and the Women’s Health Initiative
ASRM Comments to Help Guide Physicians on Hormone Therapy and the Women’s Health Initiative

Alternatives to Hormone Therapy

ASRM Annual Meeting Press Release: Menopausal Symptoms and Treatment Effects (October 2007)

Hormone Therapy and Cancer Risk

ASRM Press Release: ASRM Comments on "Ovarian Cancer and HT in the Million Woman Study," published in The Lancet, April 19, 2007
ASRM Press Release: The American Society for Reproductive Medicine Comments on “The Decrease in Breast-Cancer Incidence in 2003 in the United States”: Report to Appear in the New England Journal of Medicine (April 2007)

See also the following topics:

Return to Topic Index

By accessing and using the ASRM Web Site, you agree to be bound by
the ASRM Web Site Terms and Conditions of Use.

View the ASRM Non Discrimination Policy

Listed on Infertility Resources
Developed and hosted by Internet Health Resources